<DOC>
	<DOC>NCT02543801</DOC>
	<brief_summary>This study evaluates two routinely used drug combinations for periarticular injection following total hip arthroplasty for pain control. One group will receive liposomal bupivacaine, bupivacaine, clonidine, epinephrine and ketorolac. The other group will receive ropivacaine, clonidine, epinephrine and ketorolac.</brief_summary>
	<brief_title>A Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Hip Arthritis (osteoarthritis, post traumatic, inflammatory, and avascular necrosis) Current use of opioid drugs Revision surgery Surgical complication (femoral fracture with implant insertion) Inability to provide Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>